Skip to content

Surgical pretreatment combined with photodynamic therapy for basal cell carcinoma: a multicenter randomized, controlled, open trial

Surgical pretreatment combined with photodynamic therapy for basal cell carcinoma: a multicenter randomized, controlled, open trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038565
Enrollment
Unknown
Registered
2020-09-24
Start date
2020-10-15
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal cell carcinoma

Interventions

1:Surgical pretreatment combined with photodynamic therapy
2:Mohs surgery

Sponsors

Xiangya Hospital Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patients with primary BCC confirmed by pathological examination, including nodular type, superficial diffuse type, micronodular type, mixed type and other types of BCC; 2. in accordance with the principle of putting the interests of patients first, the number of lesions in BCC or the diameter of a single lesion >=0.5cm is recommended to be included in the control group such as Mohs, and the experimental group is recommended for lesions with large area, multiple lesions and H area such as nose; 3. sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe liver, kidney and heart disease or immune deficiency; 2. Patients with a history of mental illness and epilepsy, etc.; 3. Women during lactation or pregnancy; 4. Patients are known to have skin photosensitivity, porphyria or allergy to porphyrins; 5. People who are known to be allergic to iodine.

Design outcomes

Primary

MeasureTime frame
Complete remission rate of skin lesions at 3 months after the last treatment;

Countries

China

Contacts

Public ContactXiang Chen

Xiangya Hospital Central South University

chenxiangck@126.com+86 13975855322

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026